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ABSTRACT

COMPARATIVE EVALUATION OF MALNUTRITION SCREENING IN
ONCOLOGY PATIENTS IN AN ACUTE CARE HOSPITAL: A PILOT STUDY
by Chandni Sen Sinha

Malnutrition is associated with negative health consequences in the vulnerable cancer
population, making it imperative for an efficient interdisciplinary approach to conduct
nutritional screening using an appropriate scale. For the present study, a comparison
between an existing malnutrition risk-screening questionnaire (EMR-SQ) and a
comprehensive screening questionnaire (CMR-SQ) was performed on 37 cancer patients.
The first stage of data collection required the nurses to electronically complete the EMRSQ. In the second stage, the same patients’ data were assessed using the CMR-SQ,
developed by the authors based on the guidelines of the PG-SGA and A.S.P.E.N. The
CMR-SQ identified 32.4% at low, 37.8% at moderate and 29.7% at high risk of
developing malnutrition compared to 81.1% at low risk of developing malnutrition with
less than 20% identified at a moderate or severe risk by the EMR-SQ. The CMR-SQ
resulted in identifying a greater number of people at risk of developing malnutrition in
comparison to the EMR-SQ currently being used at Good Samaritan Hospital’s oncology
unit (p < 0.0001). The combined distribution pattern of 70% for all patients at moderate
and high risk of developing malnutrition identified by the CMR-SQ is consistent with
what is reported in the literature, indicating the prevalence of malnutrition is between 40
and 80% of the cancer patients in hospitals. The CMR-SQ may assist in time sensitive
referrals of patients with a moderate and high risk of developing malnutrition for
nutritional interventions to the registered dietitian nutritionists (RDN).
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Introduction
Malnutrition is a common complication in the cancer population, and has a negative
impact on the healthcare system. The nutrition screening process is an important first step
in identifying cancer patients with nutrition-related problems, such as malnutrition or
those with the potential risk of developing malnutrition and who may benefit from a
thorough nutrition assessment by a registered dietitian nutritionist (RDN).
The Joint Commission (1995), an independent, non-profit accreditation organization
that certifies healthcare institutions nationwide to meet certain quality standards, has
mandated that nutrition screening be performed on all hospitalized patients within 24
hours of admission. The Joint Commission, however, does not endorse a universal
nutrition screening instrument or method, nor does it specify guidelines for nutrition
screening, including which staff member should be responsible for conducting the
screening. These are currently decided by the individual healthcare facility. To adhere to
the mandate that nutrition screening be completed within 24 hours of patient admission,
hospitals use a variety of nutrition screening instruments, including a set of questions
typically administered by the nursing staff. The lack of uniform or defined procedures
and inconsistencies of the screening process, can lead to inefficient communication
between the interdisciplinary healthcare team members, as well as to a higher incidence
of morbidity and mortality in the inpatient setting. Compounding these problems, the lack
of an efficient and effective screening method may result in failing to correctly identify
patients with a risk of developing moderate and severe malnutrition.
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One of the primary objectives of this study was to compare the ability of an existing
screening questionnaire currently in use at an acute care facility with a more
comprehensive malnutrition risk screening questionnaire, developed for purposes of this
study, in identifying nutritionally at-risk cancer patients. The review of literature, as it
relates to the subject of this study, covers a broad overview of cancer, malnutrition, the
impact of malnutrition in the oncology population, nutrition screening for hospitalized
patients, and the types of popularly employed malnutrition screening instruments used in
an inpatient setting.
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Chapter 1. Literature Review
Cancer and Malnutrition
Cancer may be defined as a group of diseases that cause the cells of the body to
divide in an uncontrollable manner, producing cells that serve no purpose in the normal
functioning of the body. Some of these extra or unwanted cells may invade the
surrounding tissues and spread to other parts of the body. The National Cancer Institute
projected that in the United States in 2016 there will be 1,685, 210 diagnosed new cases
of cancer, representing the second leading cause of death, following cardiovascular
disease (U.S. Department of Health & Human Services, National Institutes of Health,
National Cancer Institute, 2016).
Cancer patients are potentially at risk of developing malnutrition, reflected by
unintentional weight loss over a specific timeframe, loss of appetite, loss of subcutaneous
fat, loss of muscle mass, presence of edema, and diminished hand-grip strength. The
incidence of malnutrition among cancer patients has been estimated to range between
40% and 80% (Bauer, Capra, & Ferguson, 2002). Researchers have also found that
malnutrition is being poorly diagnosed by nurses, who represent the first point of contact
with patients in hospitals. In one study, for example, nurses identified only 15% of
patients as malnourished, even though the nutrition instrument (Mini Nutritional
Assessment or MNA) identified 56.7% as being malnourished (Suominen, Sandelin,
Soini, & Pitkala, 2009). Malnutrition in acute care hospitals has been found to be
unidentified in 70% of cases (Kelley et al., 2000).
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Malnutrition is difficult to define, in part because it includes a wide range of
characteristics, from undernutrition to overnutrition, as well as deficiency or excess of
calorie or protein intake, or that of micronutrients such as vitamins and minerals. For
many years, there was a lack of consensus among healthcare professionals regarding an
appropriate definition of malnutrition. The American Society of Parenteral and Enteral
Nutrition (A.S.P.E.N.) has defined the term malnutrition in association with the
conditions of both undernutrition and overnutrition, with or without the presence of
inflammation, possibly reflecting acute, sub-acute, or chronic conditions leading to
adverse health effects and reduced functional capacity (White et al., 2012). For purposes
of this study, malnutrition is discussed in the context of undernutrition.
Recent Modifications to the Definition of Malnutrition
An International Guideline Committee organized by A.S.P.E.N. and the European
Society of Parenteral and Enteral Nutrition (ESPEN) developed an etiology-based
approach for the diagnosis of malnutrition in the adult population. In 2012, A.S.P.E.N.
and the Academy of Nutrition and Dietetics (AND) published a consensus statement that
endorsed these criteria, for use in clinical practice (White et al., 2012). Six different
criteria identified by the committee form the basis for a diagnosis of malnutrition (Table
1). The presence of two or more of these is required in order to arrive at a diagnosis of
malnutrition. These six criteria are: insufficient energy intake, weight loss, loss of muscle
mass, loss of subcutaneous fat, edema that may sometimes mask weight loss, and
diminished muscle strength (measured by handgrip strength). Malnutrition, may be
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identified as non-severe or severe, and may be diagnosed in the context of acute/chronic
illnesses or social/environmental circumstances.
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Table 1

Academy of Nutrition and Dietetics/American Society for Parenteral and Enteral
Nutrition Clinical Characteristics for Diagnosing Malnutrition in the Adult Population
Type of Malnutrition
Insufficient Energy
Moderate
Severe
Body Fat Loss
Moderate
Severe
Muscle Mass Depletion
Moderate
Severe
Fluid Accumulation
Moderate
Severe
Hand Grip Strength
Moderate
Severe

Acute Illness or
Injury Related
Malnutrition

Chronic Disease
Related Malnutrition

Social or
Environmental
Related Malnutrition

<75% for >7 days
≤50% or ≥5 days

<75% for ≥1 month
≤75% for ≥1 month

<75% for ≥3 month
≤50% for ≥1 month

Moderate
Severe

Moderate
Severe

Moderate
Severe

Moderate
Severe

Moderate
Severe

Moderate
Severe

Moderate
Severe

Moderate
Severe

Moderate
Severe

Not Applicable
Not recommended in
intensive care unit
Weight Loss Characteristics
Moderate
%
Time
1-2
1 week
5
1 month
7.5
3 months
Severe

%
>2
>5
>7.5

Time
1 week
1 month
3 months

Not Applicable
Not Applicable
Not recommended in Not recommended in
intensive care unit
intensive care unit
%
5
7.5
10
20
%
>5
>7.5
>10
>20

Time
1 month
3 months
6 months
1 year
Time
1 month
3 months
6 months
1 year

%
5
7.5
10
20
%
>5
>7.5
>10
>20

Time
1 month
3 months
6 months
1 year
Time
1 month
3 months
6 months
1 year

Note. The data in Table 1 have been adapted from “Consensus Statement of the Academy
of Nutrition and Dietetics/American Society for Parenteral and Enteral Nutrition:
Characteristics Recommended for the Identification and Documentation of Adult
Malnutrition (Undernutrition),” by J. White et al., 2012, Journal of the Academy of
Nutrition and Dietetics, 112, pp. 730-738. Copyright 2012 by the American Society for
Parenteral and Enteral Nutrition and the Academy of Nutrition and Dietetics. Used with
permission.
6

Prevalence of Malnutrition in Hospitalized Patients

Malnutrition is a serious condition, affecting 30-50% of hospitalized patients (Jensen,

Compher, Sullivan, & Mullin, 2013). Similarly, Gout, Barker, and Crowe (2009) found
that 40% of the patients in hospitals in Western countries were malnourished. Studies
have demonstrated that up to 69% of these patients may experience further nutritional
decline during their hospital stay (Sauer, 2014).
Malnutrition is more prevalent among cancer patients than for the general population,
with rates varying depending on the diagnosis. It has been reported that up to 85% of
patients with certain cancer diagnoses may experience weight loss. A weight loss of even
5% has been associated with decreased response to treatment and a lower rate of survival.
Hebuterne et al. (2013) reported a frequency of weight loss due to malnutrition, ranging
from 31% to 87%, depending on tumor site and stage, with the highest occurrence found
in patients with cancer of the aerodigestive tract (the organs and tissues of the respiratory
tract and the upper part of the digestive tract, collectively).
Causes of Malnutrition among Oncology Patients
Malnutrition associated with cancer is believed to be primarily due to the presence of
tumors, host responses to the tumor, and anticancer therapies, as well as the interplay of
mechanisms between the host, tumor, and deranged metabolism. All of these factors may
indirectly affect the carbohydrate, protein, fat, vitamin, and mineral metabolisms
(Van Cutsem & Arends, 2005). These alterations in metabolism are also associated with
decreased nutrient intake, loss of appetite, changes in taste, and food aversions (Van
Cutsem & Arends, 2005). Psychological factors, such as fear, depression, and anxiety,
may also be involved as causes of malnutrition. A combination of these factors,
7

psychological and other factors, may lead to an extreme form of malnutrition, known as
cancer cachexia, potentially resulting in increased morbidity or mortality.
Impact of malnutrition in the oncology population. Capuano, Gentile, Bianciardi,
Tosti, and Di Palma (2010) found the condition of malnutrition to be associated with
mortality, morbidity, increased length of hospital stay, decreased response to cancer
treatment, and increased health-care related costs. The authors conducted an observationbased study of 61 outpatients suffering from advanced head and neck cancer, reported
that malnutrition can negatively impact the quality of life and performance status.
Furthermore, the study findings indicated that an early diagnosis of malnutrition followed
by adequate nutrition support, in which nutrients are delivered via a tube placed into the
stomach or small intestine, or intravenously, could be beneficial regarding unintended
weight loss and other markers of malnutrition, as well as general quality of life (QOL).
Nutrition screening therefore plays an important role either in identifying patients who
may be malnourished at the time of hospital admission, are prone to becoming
malnourished during their hospital stay, or both.
Screening in Hospitalized Patients
Definition of screening instruments. Screening questionnaires are used in various
healthcare settings for early detection of a possible underlying disease condition in
individuals with or without the presence of signs or symptoms. Screening instruments can
be used as a preventive measure for patients who may benefit from interventions, based
on their current conditions. The screening instruments can guide healthcare providers

8

with initiating appropriate intervention and managing the condition in a time-sensitive
manner.
Commonly used screening instruments in hospitals. Examples of screening
instruments that are commonly used in hospital settings include the Braden Scale for
predicting pressure sore risk, as well as a variety of screening instruments for assessing
dementia and cognitive impairment, including the Numeric Rating Scale (NRS) and the
Visual Analog Scale (VAS), or Verbal Descriptor Scale (VDS), for assessment of acute
pain (Wewers & Lowe, 1990). The nutrition-related scales commonly used in hospitals
for screening patients at risk of developing malnutrition include: The Malnutrition
Universal Screening Tool (MUST), Nutritional Risk Screening (NRS 2002), Mini
Nutritional Assessment (MNA), Short Nutritional Assessment Questionnaire (SNAQ),
Malnutrition Screening Tool (MST), and Subjective Global Assessment (SGA)
(Anthony, 2008).
Malnutrition Screening

Nutrition screening. According to the guidelines of The Joint Commission (1997),

nutrition screening by a member of the interdisciplinary healthcare team, typically by a
nursing professional, should be performed within 24 hours of admission at an acute-care
hospital (Jensen et al., 2013). A study by Patel et al. (2014) concluded that nutrition
screening in 86% of facilities in the U.S. are conducted by nurses. This screening
represents the first step in identifying individuals who may be at risk of developing
malnutrition and may require a thorough nutrition assessment by a Registered Dietitian
Nutritionist (RDN). It is important to note that nutrition screening differs from nutrition
assessment. A nutrition assessment, conducted by a RDN, is an involved process that
9

helps identify an existing or impending nutrition problem, and includes recommendations
for possible nutrition intervention.
Significance of malnutrition screening. Early detection of an increased risk of
developing malnutrition through appropriate nutrition screening, followed by a
comprehensive nutrition assessment and treatment, is imperative for proper care of cancer
patients. A prospective three-year study conducted by Lim et al. (2012) on a group of
newly admitted patients in a tertiary level acute-care hospital in Singapore evaluated the
effect of malnutrition on the length of hospital stay, cost of hospitalization, readmission,
and mortality. The SGA instrument was used for the nutrition assessment of this study
sample of 818 patients. The highest prevalence of malnutrition was found in the patients
of the oncology unit (71%), followed by endocrinology (48%), and respiratory medicine
(47%). In comparison to the well-nourished patients (71%), the authors concluded that
the 29% of patients with malnutrition experienced longer hospital stays (6.9±7.3 days
versus 4.6±5.6 days) and were also at a higher risk of readmission within 15 days after
discharge (adjusted relative risk=1.9, p=0.025). The study authors also found the
mortality rate to be higher in the malnourished patients during the three-year period:
48.5% versus 9.9% in the well-nourished population group. The average cost of
hospitalization for the malnourished population group was found to be three times higher
than for adequately nourished patients. According to Lim et al. (2012), this implies
greater use of hospital resources, higher re-admission rates, greater risks of infections,
more pressure ulcers, and poorer wound healing.
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Another study, utilizing cross-sectional design, conducted in Korea by Wie et al.
(2010), analyzed the prevalence of malnutrition among 12,112 hospital cancer patients.
The findings indicated that 61% were malnourished, with greatest prevalence among
males. Prevalence of malnutrition was also found to be greater among patients with liver
(86.6%) and lung (60.5%) cancers, as well as advanced cancer patients (stages III or IV)
of all kinds (60.5%). The length of hospital stays of greater than 10 days (p = 0.0017) and
readmission (p < 0.0001) were found to be associated with higher risk of malnutrition in
cancer patients.
Malnutrition screening instruments for use with oncology patients. The use of an
appropriately sensitive nutrition screening instrument is important for the accurate
identification of malnutrition among oncology patients. The Patient Generated Subjective
Global Assessment (PG-SGA), modeled on the SGA screening instrument, is a validated
nutritional screening questionnaire used for the oncology population. The PG-SGA is
also used for cross-validating other screening instruments. There are three main
differences between the PG-SGA and the SGA, on which the former is modeled (Bauer et
al., 2002). First, the SGA screening instrument is used more broadly, for a variety of
medical conditions, including cancer, while the PG-SGA is used specifically for cancer
patients. Second, the SGA is scored categorically, whereas the PG-SGA is scored on a
continuous scale, that is, the higher the score, the greater the risk of developing
malnutrition. Third, the SGA screening is conducted entirely by a healthcare staff
member, in contrast with the PG-SGA, for which the first half of the form can be
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completed by the patient using check boxes, with the second half to be completed by a
healthcare professional.
The PG-SGA questionnaire consists of two sections: Part one is based on information
obtained from the patient on weight history, nutrition history, symptoms affecting normal
eating, and activities of daily living. Part two consists of worksheets that calculates
weight loss, metabolic changes related to nutritional requirements, and physical
examination based on assessment of body composition. The score obtained from the
questionnaire is then used to determine whether the patient is at mild, moderate or severe
risk of developing malnutrition (Shaw, Fleuret, Pickard, Mohammed, & Black, 2015).
Bauer, Capra, and Ferguson (2002) evaluated the PG-SGA as a nutrition screening
instrument for 71 cancer patients between the ages of 18 and 92 in an Australian hospital.
The PG-SGA demonstrated a sensitivity of 98% and a specificity of 82% for malnutrition
screening. The study concluded that the PG-SGA was a simple and efficient instrument
for screening malnutrition in cancer patients.
The lack of training or expertise in conducting nutrition screenings, however, along
with the absence of a universally accepted screening method makes it challenging for
nursing staff to conduct screening based on evidence-based guidelines. This is likely to
lead to problems associated with failure to identify nutritionally at-risk patients, with the
result that these patients would not receive appropriate care.

12

Efficiency of an Interdisciplinary Team Approach in Identifying Malnutrition
In accordance with the mandatory policies and procedures set forth by The Joint
Commission in 1997, nutrition screening is conducted within 24 hours of admission in an
acute-care facility (Jensen et al., 2013). A survey conducted by Patel et al. (2014)
concluded that out of 1,777 respondents, nurses were the primary providers for
conducting nutrition screening in 83% of the facilities in the U.S. The survey also
concluded that an interdisciplinary team approach consisting of nursing staff, physicians,
and other related healthcare providers in hospital settings is imperative for appropriate
recognition and management of malnutrition.
Despite the prevalence and the negative outcomes associated with malnutrition, and
the protocol specified by The Joint Commission implying the need for trained
professionals in identifying malnutrition, the condition remains under recognized and
even often unidentified in some healthcare care establishments (White et al., 2012) .
Furthermore, non-evidence-based approaches are not likely to identify malnutrition
accurately. For instance, Gout et al. (2009) found that malnutrition was not appropriately
diagnosed and documented in hospitalized patients. Gout et al. (2009) conducted the
study in a teaching hospital in Melbourne, Australia. The researchers analyzed the
identification of and referral rates for malnutrition among the hospitalized patients. The
SGA was used for the nutritional assessment of 275 patients upon admission. The
researchers found the rate of malnutrition to be 23%, with patients exhibiting longer
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length of stays by 4.5 days, in comparison with non-malnourished individuals. It was
found that only 15% of the malnourished population was identified accurately.
Bavelaar, Otter, van Bodegraven, Thijs, and van Bokhorst-de van der Schueren
(2008) conducted a prospective study to investigate the general protocol for identifying
and treating malnutrition by physicians, medical students, and nurses in the general
medical unit at the Vrije Universiteit Medical Center in Amsterdam. The study was
conducted in 395 patients between 19 and 96 years of age, at three stages of hospital stay:
prior to admission, during hospitalization, and after discharge. The evaluation was based
on several criteria that included body mass index (BMI), SNAQ (Short Nutritional
Assessment Questionnaire) scores (≥2 points), medical doctor referrals, nutritional
screening, and interventions at various stages, including before, during, and postdischarge. The researchers found that the medical doctors conducted only 15.3% of the
nutritional assessments, nursing staff were responsible for 30%, and the medical students
53% of the assessments. Moreover, it was also found that no nutritional intervention was
undertaken during patients' stays, and nutritional condition was not reported on the
discharge summary. Neither screening nor intervention was found to be efficient in this
hospital system.
Similar findings were reported in the study by Suominen et al. (2007), which found
that nurses were not proficient at diagnosing and documenting malnutrition. The study
examined the efficiency with which malnutrition in elderly patients living in long-term
care hospitals in Helsinki, Finland was identified, with 1,043 residents and 53 nurses
participating in the study. The residents were assessed using the MNA questionnaire, in
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conjunction with a questionnaire. Although the MNA identified 56.7% as malnourished,
the nurses recognized only 15.2% as malnourished.
In summary, a variety of nutrition-related scales are commonly used in hospitals
today for screening patients at risk of developing malnutrition. Malnutrition is more
prevalent among cancer patients than for the general population, with rates that vary,
depending on the specific diagnosis. Patients with malnutrition experience longer hospital
stays and are also at a higher risk of readmission. The mortality rate has been found to be
higher among malnourished patients, which implies greater use of hospital resources,
higher re-admission rates, greater risks of infections, more pressure ulcers, and poorer
wound healing (Lim et al., 2012).
The story that the review of the literature tells, overall, is that of glaring failure,
worldwide, to adequately identify malnourishment among hospital patients, and
subsequently to appropriately address their nutritional needs, regardless of screening
instruments used or requirements in place. The lack of a universally accepted screening
method makes it difficult for nursing staff to conduct screening based on evidence-based
guidelines. This is likely to lead to problems associated with failing to identify
nutritionally at-risk patients, with the likely result that these patients will not receive
appropriate care. At the same time, what the literature highlights is that an
interdisciplinary team approach consisting of nursing staff, physicians, and other related
healthcare providers in hospital settings is imperative for appropriate recognition and
management of malnutrition (Patel et al., 2014).
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The review of the literature exposed a set of problems resulting from acute care
hospitals, requiring nursing staff to perform nutritional screening, which would best be
delegated to RDNs, nutrition experts with the knowledge and skill set to effectively
identify nutritionally at-risk patients. This study was designed to address both dimensions
of this set of problems: the screening instrument, and its use by healthcare professionals.
One of the study objectives was to determine whether the existing nutritional
screening process could be improved upon, by substituting a more comprehensive and
sensitive screening instrument (CMR-SQ) for the instrument currently in use (the EMRSQ) at Good Samaritan Hospital (GSH) oncology unit in San Jose, California. The
rationale for exploring this potential improvement is evident from the review of literature.
The nursing staff members at acute-care hospitals tend to lack the skills and knowledge
necessary for identifying nutritionally at-risk patients. This is further demonstrated by the
screening results utilizing the EMR-SQ instrument, which identified most of the patients
(81%) being in the low-risk category. Moreover, because of issues with the reliability of
the EMR-SQ as a screening instrument, the RDNs at the hospital devoted long hours to
reading through complex medical histories, for the sake of ensuring that patients who
were potentially at nutritional risk were being identified appropriately, in a time-sensitive
manner, and were receiving proper nutritional intervention.
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Chapter 2. Journal Article
COMPARATIVE EVALUATION OF MALNUTRITION SCREENING
IN ONCOLOGY PATIENTS IN AN ACUTE CARE HOSPITAL: A PILOT STUDY
Chandni Sen Sinha 1 (MS Candidate); Colette LaSalle1,3, PhD, RD; Debra Argabright2,
MS, RD; Clarie B. Hollenbeck1, PhD
1

Department of Nutrition, Food Science and Packaging, San José State University, San

José, California
2

Good Samaritan Hospital, San José, California

3

Corresponding author

Keywords: cancer, malnutrition, nutrition screening, screening instrument
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Abstract
Background. Malnutrition is associated with negative health consequences in the
cancer population, making it imperative for an efficient interdisciplinary approach to
conduct nutritional screening using an appropriate instrument. The present study
compared the qualitative evaluation of nutritionally at-risk cancer patients, using an
existing malnutrition risk-screening questionnaire (EMR-SQ), with a new comprehensive
questionnaire (CMR-SQ).
Materials and methods. The population studied consisted of 37 cancer patients. The
first stage in data collection involved assessment by the nurses, utilizing the EMR-SQ. In
the second stage, these same patients were evaluated using the CMR-SQ developed by
the authors, containing components specific to identifying individuals at-risk for
malnutrition, based on the PG-SGA and A.S.P.E.N. guidelines. The risk scores were
subsequently used to classify low, moderate, and high risk of developing malnutrition.
Results. The EMR-SQ identified 81.1% at low risk of developing malnutrition,
whereas the CMR-SQ determined 32.4% low, 37.8% moderate, and 29.7% at high risk.
These differences between the screening instruments were statistically significant (p <
0.0001). Correlational analyses of factors affecting the risk of developing malnutrition
using Spearman’s rho indicated a positive relationship in presence of co-morbidities r =
0.63, p < 0.010 and an inverse relationship between handshake strength r = -0.40, p <
0.05.
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Conclusion. The combined distribution pattern of 70% for moderate and high risk of
developing malnutrition identified by the CMR-SQ is consistent with the estimates of
prevalence of malnutrition in hospitalized cancer patients in the literature. The increased
sensitivity of the CMR-SQ could be attributed to the addition of nutrition focused clinical
characteristics.
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Introduction
Malnutrition is the result of a serious decline in the nutritional status of individuals. It
may be characterized by unintentional weight loss, loss of muscle mass, loss of
subcutaneous fat, fluid accumulation, and reduced physical function. Malnutrition
represents a major problem for the modern healthcare system and the community at large.
Significantly, Gout, Barker, and Crowe (2009) found that 40% of hospitalized patients in
Western countries were malnourished.1
Malnutrition, which is particularly challenging among cancer patients, may arise from
interaction between a tumor, the host’s response to the tumor’s growth, and anticancer
therapies.2 An estimated 30-50% cancer patients die because of cachexia, 3 an extreme
form of malnutrition characterized by severe muscle wasting. Malnutrition has been
associated with a host of negative consequences in cancer patients, including increased
length of hospital stay, impaired tolerance to cancer treatments, and increased health-care
related costs.4
The Joint Commission (1997), an independent, non-profit accreditation organization
that certifies healthcare institutions nationwide to meet certain quality standards, has
mandated that nutrition screening be performed on all hospitalized patients within 24
hours of admission.5 The Joint Commission does not endorse a universal nutrition
screening instrument or method, however, nor does it specify particular guidelines for
nutrition screening, including which staff member should be responsible for conducting
the screening. These are currently decided by the individual healthcare facility. To adhere
to the mandate that nutrition screening be done within 24 hours of patient admission,
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hospitals use a variety of nutrition screening instrument, including a set of questions
typically administered by a nursing staff member. The resulting variations and
inconsistencies of the screening process can lead to inefficient communication between
the interdisciplinary healthcare team members and to higher incidences of morbidity and
mortality in the inpatient setting.5
The objectives of the present study were three-fold: First, to compare the malnutrition
screening questionnaire currently used within the oncology unit (EMR-SQ) at Good
Samaritan Hospital (GSH), a large metropolitan hospital in the San Francisco Bay Area,
with a more comprehensive questionnaire (CMR-SQ), to determine their relative ability
to detect patients at-risk for developing malnutrition. Second, to determine the
distribution of patients identified under the categories of low risk, moderate risk, or high
risk. Third, to determine the variables that may be more sensitive indicators of identifying
patients at a potential risk of malnutrition particularly at moderate along with high risk.
Materials and Methods
Study design and patient population. The study was approved by the Institutional
Review Board (IRB) of both GSH and San Jose State University (SJSU), both in San
Jose, California. Written informed consent was obtained prior to initiation of the study.
The study was conducted in the oncology unit at GSH. The patients recruited for the
study were newly admitted to the unit and data were collected within 24 hours of
admission. Inclusion criteria for the study called for newly admitted cancer patients 18
years and older, the ability to understand English and follow oral instructions, and
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voluntary participation in the study. Signs of impaired cognition, as well as the failure to
meet the inclusion criteria, constituted the exclusion criteria.
Screening questionnaires. Two separate screening questionnaires were involved in
this study. The first was the existing malnutrition screening questionnaire, which for
purposes of this study is referred to as the EMR-SQ. The second screening questionnaire
was a more comprehensive malnutrition risk screening questionnaire, developed to
identify the nutritionally at-risk cancer patients, referred as the CMR-SQ.
The CMR-SQ was developed by the investigators based on The Patient Generated
Subjective Global Assessment (PG-SGA). The PG-SGA is a validated nutritional
screening questionnaire used for the oncology population. The PG-SGA consists of two
sections6: Part one is based on information obtained from the patient on weight history,
nutrition history, symptoms affecting normal eating and activities of daily living. Part two
consists of worksheets that calculate weight loss, metabolic changes related to nutritional
requirements, and physical examination based on assessment of body composition. The
CMR-SQ also incorporated certain nutrition focused clinical characteristics, such as, the
presence of co-morbidities, handgrip strength measurement, physical assessment,
medications, lab values, more in-depth assessment of weight changes, along with the
duration, and factors affecting loss of appetite. Furthermore, the CMR-SQ grouped
different cancers based on an associated nutrition risk score. For example, cancer
involving the reproductive system was assigned a score of one because of the relatively
lower impact this cancer has regarding the nutritional status. Conversely, cancers of the
lung, stomach, and colorectum were assigned a score of three, as these cancers are known
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to have a significant impact on patients' nutritional status. 7 Cancers of the pancreas, head
and neck, mouth, pharynx, esophagus, and liver were assigned the highest score (six),
indicating the greatest level of nutritional risk.7 Finally, early stage cancers were assigned
lower nutritional impact scores than cancers in later stages (two, three, and four). 7The
score obtained from the questionnaire is then used to determine whether the patient is at
low, moderate, or high risk of developing malnutrition. 6
Data collection. Data were collected from 37 participants during a three-month
period, from mid-March to mid-June 2015. The data collection process included two
stages. The first stage involved an electronically completed EMR-SQ that included the
patients’ nutritional status, followed by assignment of a nutrition risk score of either level
1 (high risk), level 2 (moderate risk), or level 3 (low risk), based on the malnutrition
diagnosis grid developed and used within the hospital. The assessment included: the
patient’s name, date of birth, age, sex, reason for the visit, primary diagnosis, chief
complaint, allergies (if any), any swallowing difficulty affecting food intake, tube feeding
or total parenteral nutrition (TPN), dietary restrictions, unintentional weight loss of ten
pounds or more, very poor appetite for more than five days, recent onset of diabetes (less
than 3 months), anthropometrics, abdomen appearance, gastrointestinal comment,
pressure ulcer, Braden skin score, and any previous surgeries.
The second stage of the patients’ nutritional status was assessed using the CMR-SQ.
Specifics related to weight history, food intake, and appetite were gathered by
interviewing the patient. A nutrition-focused physical exam and handshake for assessing
the handgrip strength were also conducted on the patients. Data on existing treatment
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including general chemistry/lab values, current diagnosis, comorbidities, and medications
were obtained from the patient’s admission history, physician assessments, and hospital
progress notes. After assigning a score to each item in the questionnaire, the scores were
totaled, with each patient assigned a nutrition risk level, 1 (low risk), 2 (moderate risk), or
3 (high risk), based on the total score. These nutrition risk level scores were assigned in
accordance to the PG-SGA screening questionnaire.
Data analysis. Data were analyzed using SPSS version 22.0 (SPSS, Chicago, IL,
USA). Comparison of assigned risk levels between the two questionnaires was assessed
utilizing the Wilcoxon Signed-Rank Test. Correlational analyses using Spearman’s rho

and Kendall’s tau  were used to examine the relationships between study variables, such
as weight change, factors affecting appetite loss, presence of co-morbidities, and
handshake strength, and their placement into one of the three at-risk levels. The level of
statistical significance was specified at p ≤ 0.05 level. A level of clinical significance
regarding the distribution of nutritionally at-risk individuals was defined as a level of
distribution more consistent with the published literature, which estimates the prevalence
of moderate to severe malnutrition between 40% and 80% among cancer patients. 8
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Results
Clinical and demographic characteristics. The clinical and demographic
characteristics of the 37 patients are provided in Table 1. Their ages varied between 23
and 95 years, with a mean  SD of 67  15 years. The mean ± SD body mass index

(BMI) was 25.8 ± 5.24. The study group included three outliers, two with BMIs of 37.3
and 42.4 kg/m2, as well as one outlier on the other end of the spectrum, with a BMI of
18.0 kg/m2. Gender distribution was essentially equal.
Weight history. Subjects ranged in weight from 45 kg to 105 kg, with a mean ± SD
weight of 73.4 ± 16.74 kg (Table 1). Fourteen of the 37 individuals (37.8%) reported
weight loss during the 30 days prior to admission; of these, 11 (78.6%) reported a loss of
10-20 pounds (4.5 to 9 kg); three of the 14 (21.4%) reported a loss between 21 and 30
pounds (9.5 to 13.6 kg). On the other hand, only three of the 37 subjects (8.1%) reported
a weight gain, ranging from 10 to 20 pounds (4.5 to 9 kg) during the 30 days prior to
hospitalization.
Cancers. The most frequently reported cancers, accounting for 22 of the 37 patients
(59%) diagnosed with cancer, involved either the reproductive system (affecting one or
both breasts, the prostate, the endometrium, or the cervix) or one or both kidneys (Table
1). The next most commonly reported cancers, accounting for 13 of the 37 patients (35%)
diagnosed with cancer, related to the lungs, stomach, and colon. The least commonly
reported cancers, accounting only two of the 37 patients (5%) diagnosed with cancer,
involved the pancreas, head and neck, pharynx, esophagus, and liver.
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Table 1
Clinical and Demographical Characteristics of Study Participants for Malnutrition
Screening in the Oncology Unit at Good Samaritan Hospital
Mean  SD
(%)
67.0  15.2
168.1  11.1
73.4  16.8
25.81  5.2

Clinical characteristics

Age (yr)
Height (cm)
Weight (kg)
Body Mass Index (kg/m2)
Gender (M/F)
No change in weight
Decreased weight
10-20 lb
21-30 lb
Increased weight
10-20 lb
21-30 lb
>30 lb

Weight history

Type of cancer
Breast/Prostate/Endometrium/Cervix/Kidney
Lung/Stomach/Colon
Pancreas/Head/Neck/Pharynx/Esophagus/Liver

n
(%)

18M/19F
(49/51)
20 (54)
14 (38)
11 (30)
3 (8)
3 (8)
0 (0)
0 (0)
22 (60)
13 (35)
2 (5)

Note. Yr = years; kg = kilogram; kg/m2 = kilogram per meter squared; F = female;
M = male; lb = pound
Appetite. Duration and factors affecting appetite loss are presented in Table 2.
Patients experiencing very poor appetite on CMR-SQ were equally distributed, with 19
(51.4%) presenting with very poor appetite and 18 out of 37 patients (48.6%) not
reporting poor appetite during the 30 days prior to hospital admission. Of the majority of
patients presenting with loss of appetite, 8 of 19 (42%), reported less than a week of this
condition. Among the factors that may have contributed to loss of appetite, 14 of 19
patients (73.7 %) did not identify any of the factors listed on the questionnaire as possible
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choices (including "other") associated with their loss of appetite loss, while 8 of 19 (42%)
identified nausea, vomiting, and diarrhea as being associated with their loss of appetite.
Overall, nausea (74%), vomiting (68%), and diarrhea (63%) were the most common
factors associated with loss of appetite.
Table 2
Duration and Factors Affecting Appetite Loss in Study Participants for Malnutrition
Screening in the Oncology Unit at Good Samaritan Hospital
Appetite

Frequency (%)

Loss of Appetite
No
Yes
Duration of appetite loss
<1 week
1-2 week
>2 weeks
Factors Affecting Appetite Loss
Nausea
Vomiting
Diarrhea
Mouth Sores
Constipation
Dry mouth
Loose dentures
Taste Changes

18 (48)
19 (51)
8 (42)
6 (13)
5 (26)
14 (74)
13 (68)
12 (63)
2 (10)
4 (21)
5 (26)
0 (0)
9 (47)

Additional diagnoses/co-morbidities. Co-morbidities commonly observed in the
oncology unit were listed under this category. For example, three patients (8.9%)
presented with renal disease or hepatitis. This was followed by diabetes, present in the
medical records of five patients (14%). Only two patients (5%) presented in the category
of failure to thrive/malnutrition/cachexia.
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Table 3
Associations between weight change, appetite loss, co-morbidities and handshake
strength and level of risk of malnutrition
Variables

r

Kendall’s tau-
r2

p value

0.130

0.02

Weight change

0.370

0.137

Co-morbidities

0.560

0.314

Factors affecting
appetite loss
Handshake strength

0.360

– 0.370

0.137

r

Spearman’s rho
r2

p value

0.176

0.01

0.016

0.400

0.160

0.0001

0.630

0.397

0.015

0.420

– 0.400

0.160

0.014

.0001

0.014

Note. r = Correlation coefficient; r2 = Coefficient of determination; Statistical
significance = P < 0.0001
Statistically significant results on correlations and null hypothesis. Presented in
Table 3 are the correlations between weight change, appetite loss, comorbidities, and
handshake, the dependent variables on the questionnaires, and the levels of risk of
malnutrition. Results from Spearman’s rho indicated statistically significant positive
relationships between three particular variables, weight change (r = 0.40, p < 0.05),
factors affecting appetite loss (r = 0.42; p < 0.05), and presence of co-morbidities (r =
0.63; p < 0.01), and an inverse relationship between handshake strength (r = – 0.40; p <
0.05) and the level of risk with regard to developing malnutrition.
Results of the Wilcoxon-Signed Rank Test of the null hypothesis, that there is no
difference between the two screening instruments, indicated that the difference between
the two screening instruments was below the critical level. This leads to rejection of the
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null hypothesis and conversely, support for the alternate hypothesis, that there is a
significant difference between the two screening instruments (p = 0.0001).
Clinical laboratory analysis. The total WBC counts of less than 4,500 and greater
than 11,000 per microliter (mcL) were reported as the most common laboratory
abnormality, among 10 of the 37 (27%) hospitalized patients. This was followed by blood
urea nitrogen (BUN) levels greater than 50 mg per deciliter (dl), in three (8%) of the
patients.
Handshake. The handgrip strength of 19 out of 37 patients (51%) was assessed as
normal, while the handgrip strength of 15 (41%) was assessed as strong. It should be
noted that the CMR-SQ incorporated both handshake and handgrip strength
measurements. For the actual study, only the handshake measurements were included in
data analysis.
Physical assessment. The CMR-SQ also involved a section on physical assessment,
covering five physical attributes, protruding clavicle, depression of temporal area, sunken
orbital sockets, dark circle around eyes and shoulder squaring, potentially relating to
nutritional condition, which are relatively easy to observe. None of the study participants
exhibited any abnormal findings in this regard.
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Differences between the two questionnaires, EMR-SQ and CMR-SQ. As presented
in Table 4, the EMR-SQ identified 30 of the 37 patients (81%) as being at low risk for
malnutrition, while five of the 37 (14%) were identified as being at moderate risk, and
only two (5%) at high risk. The CMR-SQ, in contrast, identified 12 of the 37 patients
(32%) as being at low risk, 14 (38%) at moderate, and 11 (30%) at high risk for
developing malnutrition.
Table 4
Comparison of Nutrition Risk Scores in the Questionnaires EMR-SQ and CMR-SQ for
Malnutrition Screening in the Oncology Unit at Good Samaritan Hospital
EMR-SQ
Low
Moderate
High
CMR-SQ
Low
Moderate
High

Frequency (%)
30 (81)
5 (14)
2 (5)
12 (32)
14 (38)
11 (30)

Note. EMR-SQ = Existing Malnutrition Risk Screening Questionnaire; CMR-SQ =
Comprehensive Malnutrition Risk Screening Questionnaire
Discussion
The purpose of the present study was three-fold. The first purpose was to determine
the distribution of patients identified under the categories of: low, moderate, or high risk
of developing malnutrition, between two screening questionnaires (EMR-SQ and CMRSQ). The second purpose was to compare the EMR-SQ that is currently being used with
a more comprehensive nutritional screening questionnaire (CMR-SQ) and to examine
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whether the CMR-SQ is better able to detect nutritionally at-risk patients than the EMRSQ. The third purpose of the study was to identify potential variables included in the
CMR-SQ that may have contributed to increasing the ability in identifying patients who
are potentially at increased nutritional risk for developing malnutrition.
A comparison between the two screening questionnaires clearly indicates that there
were major differences in their ability to identify individuals with moderate and high risk
of malnutrition. The CMR-SQ identified 32.4% at low, 37.8% at moderate and 29.7% at
high risk of developing malnutrition, while the EMR-SQ identified less than 20% at a
moderate or high risk, with the vast majority of patients (81.1%) being classified at low
risk of developing malnutrition. Thus, the CMR-SQ was capable of identifying a greater
number of patients who were potentially at an increased risk of developing malnutrition
(p < 0.001). Moreover, the distribution pattern identified by the CMR-SQ is consistent
with recent evidence in the literature that reported the prevalence of malnutrition between
40% and 80% among the hospitalized cancer patients in typical western hospitals. 1,5,8-11
There were certain aspects of the CMR-SQ identified in the present study that
potentially increased the precision and sensitivity of the CMR-SQ, contributing to the
greater number of patients identified at moderate and high risk of potentially developing
malnutrition. As weight loss is a strong indicator of prognosis in the cancer patients,
weight history recorded by the CMR-SQ allowed for a much more in-depth analysis.
There were three main variables, current body weight, usual body weight (UBW), history
and degrees of weight changes specifically with regard to the previous 30 days. The
addition of weight changes to the CMR-SQ is consistent with similar screening
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instruments designed for the adult hospitalized patients including patients with cancer. 1213

In contrast, the EMR-SQ assessed patients based only on current body weight and

unintentional weight loss of more than ten pounds.
Anorexia, a severe form of loss of appetite, is common among cancer patients and
may potentially lead to malnutrition. In the CMR-SQ, poor appetite, for less than one
week, one to two weeks, or more than two weeks was further associated with eight
factors that could have possibly affected appetite loss in the cancer patients. These factors
that were associated with decreased food intake prior to admission to the hospital
included, nausea, vomiting, diarrhea, mouth sores, constipation, dry mouth, loose
dentures, and change in taste. The addition of these questions to CMR-SQ was consistent
with other studies in this area involving screening cancer patients. 13 The EMR-SQ, on the
other hand, only identified patients with poor appetite for more than five days, as well as
with difficulty swallowing, which may have affected food intake.
A measure evaluating handgrip strength of patients that was not in the current
practice was introduced in the CMR-SQ. The strength of the coefficient of determination
suggest that approximately 14% (r2=0.137) of the variation in degree of risk was related
to handshake strength. This finding is consistent with the evidence in the literature
indicating that patients demonstrating a higher handgrip strength had a decreased risk of
being nutritionally at-risk.14
The CMR-SQ, unlike the EMR-SQ, included a wide range of co-morbidities that are
commonly observed in the oncology unit at Good Samaritan Hospital. The strength of the
coefficient of determination suggest that approximately 40% (r2=0.396) of the variation
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in placement in the three categories was related to co-morbidities. This is considered
clinically significant in assessing the risk of malnutrition. However, research is limited in
the area exploring the association of comorbidities and malnutrition within the cancer
population.
Nutritional status was also assessed using five physical attributes, potentially relating
to nutritional condition, which were relatively easy to observe. The addition of these
physical attributes were consistent with the A.S.P.E.N. guidelines for detecting
malnutrition among hospitalized patients and other nutrition screening questionnaires in
this area involving screening of cancer patients.15 These identifiers, however, were not
present in the EMR-SQ.
Corticosteroids are commonly used in cancer patients to help prevent side effects
such as nausea, vomiting to anticancer treatment, as appetite stimulants, and also in pain
management. 16 The addition of these medications to the CMR-SQ was unique, especially
for malnutrition screening among the cancer patients, and may have enhanced the ability
to identify the nutritionally at-risk patients. However, none of the other popularly used
malnutrition screening questionnaires, such as the PG-SGA, SGA, MNA, NRS-2002
have incorporated the use of medications.17 The EMR-SQ, on the other hand, did not
assess patients based on current medications.
Finally, lab values with potential relevance to nutrition status were also identified
using the CMR-SQ, in contrast with the existing practice, which did not take this
information into consideration. The inclusion of lab values in CMR-SQ was also another
unique addition that was not found in any of the other screening questionnaires.
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Study limitations. The present study had several limitations. First, information
obtained on weight history and loss of appetite in the assessment of malnutrition on the
CMR-SQ was self-reported by the patients, with no independent verification regarding
the accuracy of these data. Self-reporting, a common technique of assessing patient’s
weight changes and food intake, has been adopted by several nutrition screening
questionnaires, including the PG-SGA.12 Second, information concerning edema, which
could have affected a person’s nutritional status and constituted one of the criteria for
malnutrition assessment under the A.S.P.E.N. guidelines 5, was not included in the CMRSQ. In the present study, there were two participants with edema who may have been at a
higher risk of malnutrition. Other conditions (e.g., dyspnea, pleural effusion, and severe
abdominal pain) that may have affected appetite and thereby affected risk of malnutrition
were identified in nine patients. However, these problems were not assessed on the CMRSQ under comorbidities, which could have potentially impacted the nutritional status of
the patients. Third, information on dietary intake and nutritional supplements with
possible effect on nutritional status was not collected by the CMR-SQ. These limitations
are the same for both questionnaires and therefore in the nature of the data collected.
Study strengths. A strength of the present study was that the CMR-SQ was
specifically designed for malnutrition screening of the oncology population. This
contrasted with the EMR-SQ, which was designed for general medical and physical
assessment, and was also not specifically designed to assess the nutritional status.
Moreover, even though the CMR-SQ did not include all variables that might have helped
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to accurately assess a patient's risk for malnutrition, it did include substantially more than
the EMR-SQ in standard use, as explained above.
Conclusion
Evidence from the results of the present study clearly indicated that the EMR-SQ as
an initial nutrition screening instrument was not highly effective, in the sense that it
skewed the majority of nutritionally at-risk patients into the low risk level for developing
malnutrition. In the inpatient setting, the typical timeframe for being assessed by a RDN
for mildly at-risk individuals is 72 hours. For moderately at-risk patients, the timeframe is
24 to 48 hours, while for severely at-risk patients, it is 24 hours. However, as the EMRSQ had a tendency to place most patients into the lower risk level of developing
malnutrition, patients who were actually at a higher risk may have been overlooked and
therefore not assessed by a dietitian in an appropriately time-sensitive manner. The
CMR-SQ, in contrast, was more comprehensive and specific to nutrition assessment, thus
was capable of better identifying individuals at a moderate or higher risk of developing
malnutrition, with roughly equal distribution at the low, moderate, and high levels. The
distribution pattern of percentages at the three levels of risk obtained using the CMR-SQ
is consistent with the documentation in the literature in this area suggesting that
malnutrition is prevalent in 30-85% of hospitalized cancer patients. 8-11 Hence, the CMRSQ appears to be more sensitive and precise than the percentages obtained with the EMRSQ.
The present study highlighted the importance of an instrument that is specifically
designed to assess the risk of malnutrition by incorporating the nutritionally relevant
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information. This will provide a more sensitive indication of an individual’s actual risk
for developing malnutrition. In this regard, the study highlights the importance of the
RDN as an integral member of the interdisciplinary healthcare team. The use of an
appropriately developed instrument based on important nutritional markers of nutritional
status conducted by formally trained healthcare professionals would assure more timesensitive referrals for nutrition related interventions, that can help reduce morbidity and
mortality, especially with regard to moderate and high risk individuals.
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Chapter 3. Summary and References
Summary
Malnutrition in the cancer population is associated with deleterious health
consequences. This includes cancer cachexia, a complex form of malnutrition leading to
loss of lean body mass, wasting of muscles, and diminished mental and physical capacity.
Together, these conditions can cause diminished response to cancer treatment and
decreased quality of life, as well as increased morbidity and mortality, among
malnourished cancer patients.
The Joint Commission has mandated that nutrition screening be performed for
hospitalized patients within 24 hours of admission. Nurses are typically the first point of
contact with the patients and at many hospitals are also responsible for conducting the
nutrition screening. However, the lack of an effective and widely accepted screening
method approved by The Joint Commission, as well as the lack of guidelines for nutrition
screening, makes the task difficult. The screening instrument currently in use tend to
create problems with regard to effective identification of nutritionally at-risk patients,
especially those at a moderate and high level of risk for malnutrition. The likely result of
this failure is that those patients most in need of timely nutrition intervention may not
receive it.
This study on 37 cancer patients compared an existing malnutrition risk-screening
questionnaire (EMR-SQ), in use at an acute care hospital, with a new questionnaire
(CMR-SQ), developed by the authors. The study sought to compare the qualitative
evaluation of nutritionally at-risk cancer patients based on the existing malnutrition risk-
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screening questionnaire (EMR-SQ) with a new comprehensive questionnaire (CMR-SQ),
determining the distribution of patients identified as being at low, moderate, or high
levels of risk for developing malnutrition. The EMR-SQ skewed 81.1% at the low level
of nutritional risk, whereas the CMR-SQ resulted in a more equal distribution at the three
levels of low, moderate, and high: 32.4%, 37.8%, and 29.7%, respectively. Statistical
analysis suggested that the CMR-SQ was more sensitive and precise at identifying
individuals at the three risk levels of developing malnutrition, probably because of the
addition of clinical characteristics, which is crucial for ensuring appropriate timesensitive nutrition interventions.
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Appendix A: EMR-SQ
GOOD SAMARITAN ADMISSIONS
ADULT NUTRITION RISK ASSESSMENT DATA REPORT

RUN DATE:
RUN TIME:
RUN USER:
From Admit Date:

To Admit Date:

Isolation:
Visit Reason:
Primary Diagnosis:
Chief Complaint:

Code Status:
Att. MD:

Allergies:
ADRS:
Swallowing difficulty affecting food intake:
Tube Feeding or TPN: Y/N

Dietary Restriction: Y/N

Diet Restriction:

Unintentional weight loss>= 10#: Y/N
Specify___________________
Very poor appetite for greater than 5 days: Y/N
Diabetes -New onset (less than 3 months): Y/N
Diet:
Service Date:
Ordering MD:
Entered by:
TPN/TF:_________________________
Weight kg:
Height:
BMI:
Abdomen appearance:
GI Comment:
Pressure Ulcer >=
Braden Skin Score:
Braden Skin Risk:
Medical History
Recreational drugs: Y/N
Cardiovascular: Y/N
Gastrointestinal: Y/N
Cancer: Y/N
Alcohol: Y/N
Respiratory: Endocrine/Immune: Y/N
Previous surgeries:
Level of risk of nutrition compromise: _______________________________________
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Appendix B: CMR-SQ
Oncology Screening Tool (updated 12/06/14)
1. Weight history

Current weight _______ lbs

Height ______ feet _______ inches

Usual body weight (UBW) _______lbs

When did you last weigh UBW?_________

Did you lose weight unintentionally in the past 30 days?
If decreased:

10-20lbs (2)

If increased:

BMI ________ kg/m2

No change (0)

10-20lbs (1)

Have you experienced very poor appetite?
If yes:

21-30lbs (4)
21-30lbs (2)

How long ago was patient’s usual weight known?

2. Food intake

decreased

No (0)

Less than 1 week (1)

Yes

1-2 weeks(2)

Have the following problems kept you from eating prior to admission (check all that apply):

increased

>30lbs (6)
>30lbs (3)

>2 weeks (3)

Nausea greater than 24 hours(1)

Vomiting greater than 24 hours (1)

Diarrhea/ loose bowels greater than 24 hours (1)

Loose Dentures/missing teeth (1)

Change in taste (2)

Other (1) specify: ____________

Mouth sores (1)

Constipation (1)
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Dry mouth (1)

3. Existing treatment:

Appetite stimulants(1 point)
Corticosteroids(1 point)
Antidepressant(1 point)
Other(1 point):

Megestrolacetate

Dexamethasone

Mirtazapine

Thalidomide

Dronabinol

Methylprednisolone

Olanzapine

Breast/Prostate/Endometrium/Cervix/Kidney(1)

neck/Oral/Pharynx/Esophagus/Liver(2)
Additional diagnosis:
AIDS(1)

DKA(6)

Fistulas(2)

Sepsis(1)

Pulmonary disease(1)

Pressure ulcer stage 1(1)

4.General chemistry/lab values
GFR 15-60(1)

GFR <15(2)

Lipase/Amylase>400U/L(1)

Lung /Stomach/Colorectal(2)

Newly diagnosed/Stage 1 (1)

Crohn’s, diverticulitis, ulcerative colitis(3)

Diabetes mellitus/GDM(1)

Prednisolone

Cyproheptadine

Pentoxifylline

4: Current diagnosis
Cancer

Medroxyprogesterone

Pancreas/Head &

Newly diagnosed stage 2, 3, 4(2)

Bowel obstruction(1)

Pancreatitis/Cirrhosis(1)

COPD/Congestive Heart Failure (CHF)(1)

Pressure ulcer stages2,3,4(6)

HgBA1c >7% (2)

Renal/Hepatic Disease(1)

Failure to thrive/malnutrition/cachexia(6)

SGOT & SGPT> 100 U/L(1)

BUN>50 mg/dl or <6 mg/dl(1)

Creatinine<0.5 mg/dl(1)

Total WBC count<4.5 or >11(1)
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5. Handshake
Weak (2)

Normal (0)

Strong (0)

6. Hand-grip strength measurement
Weak (3)

Normal (0)

Strong (0)

7. Physical assessment
Present

If present:

Not present (0)

Protruding clavicle

Shoulder squaring

Depression of temporal area

Score based on symptoms present: 0-1(0) 2-3(3) +3(6)
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Sunken orbital sockets

Dark circle around eyes

